Episode

What's Next in Weight-Loss Drugs?

Podcast: JAMA Medical News
Published: Jan 30, 2026
Duration seconds: 380
Processing state: not_requested
Canonical source: https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2026.959
Audio: https://traffic.libsyn.com/secure/jamamedicalnews/Whats_Next_in_Weight-Loss_Drugs_1.mp3?dest-id=525944
JSON: /v1/public/podcasts/jama-medical-news-779603/episodes/what-s-next-in-weight-loss-drugs
Markdown: /podcast/jama-medical-news-779603/what-s-next-in-weight-loss-drugs.md

Actions

POST https://stenobird.com/v1/public/podcasts/jama-medical-news-779603/episodes/what-s-next-in-weight-loss-drugs/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/jama-medical-news-779603/what-s-next-in-weight-loss-drugs.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year." Related Content: Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year